Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Professor Josef Vormoor

Newcastle AuthorsTitleYearFull text
Liz Matheson
Huw Thomas
Marian Case
Dr Helen Blair
Rosanna Jackson
et al.
Glucocorticoids and selumetinib are highly synergistic in RAS pathway mutated childhood acute lymphoblastic leukemia through upregulation of BIM2019
Professor Olaf Heidenreich
Professor Josef Vormoor
Epidemiology and biology of relapse after stem cell transplantation2018
Professor Olaf Heidenreich
Professor Josef Vormoor
The MLL recombinome of acute leukemias in 20172018
Dr Britta Vormoor
Professor Gareth Veal
Melanie Griffin
Professor Julie Irving
Lynne Minto
et al.
A phase I/II trial of AT9283, a selective inhibitor of aurora kinase in children with relapsed or refractory acute leukemia: challenges to run early phase clinical trials for children with leukemia2017
Dr Alex Elder
Dr Simon Bomken
Dr Ian Wilson
Dr Helen Blair
Dr Simon Cockell
et al.
Abundant and equipotent founder cells establish and maintain acute lymphoblastic leukaemia2017
Professor Andrew Pearson
Dr Pamela Kearns
Professor Josef Vormoor
Early phase clinical trials of anticancer agents in children and adolescents - an ITCC perspective2017
Professor Andrew Pearson
Professor Josef Vormoor
From class waivers to precision medicine in paediatric oncology2017
Professor Josef Vormoor
Geoff Bell
"Including" Patients in the North. Development of an Early Phase Trials Network in the North of Britain2016
Judith Weiland
Dr Deepali Pal
Marian Case
Professor Julie Irving
Dr Frida Ponthan
et al.
BCP-ALL blasts are not dependent on CD19 expression for leukaemic maintenance2016
Dr Deepali Pal
Professor Olaf Heidenreich
Professor Josef Vormoor
Dormancy Stems the Tide of Chemotherapy2016
Dr Lynsey McKenzie
Dr Sirintra Nakjang
Dr Helen Blair
Professor Josef Vormoor
Professor Olaf Heidenreich
Identification of CCND2 As a RUNX1/ETO Target Required for Leukaemic Propagation2016
Dr Deepali Pal
Dr Helen Blair
Dr Alex Elder
Katie Dormon
Dr Kate Rennie
et al.
Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia2016
Dr Alex Elder
Dr Klaus Rehe
Dr Simon Bomken
Dr Paul Sinclair
Katie Dormon
et al.
The ability to cross the blood-cerebrospinal fluid barrier is a generic property of acute lymphoblastic leukemia blasts.2016
Katie Dormon
Elda Latif
Dr Matthew Bashton
Dr Deepali Pal
Dr Helen Blair
et al.
A Whole Genome In Vivo Crispr Screen in Primary ALL Predicts Leukaemic Relapse2015
Judith Weiland
Dr Alex Elder
Dr Victoria Forster
Professor Olaf Heidenreich
Professor Josef Vormoor
CD19: A multifunctional immunological target molecule and its implications for Blineage acute lymphoblastic leukemia2015
12345678910